Best Ophthalmologists for Age-Related Macular Degeneration (AMD) in Mumbai, India
This page lists 3 age-related macular degeneration (amd) doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
Quick answer
This page lists 3 age-related macular degeneration (amd) doctors in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Age-related Macular Degeneration (AMD) doctors in Mumbai, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
About the Condition
What is Age-related Macular Degeneration (AMD)?
Age-related macular degeneration (AMD) is a progressive eye condition that affects the macula — the small central area of the retina responsible for sharp, detailed vision — and is one of the leading causes of significant vision loss in adults over 50. The condition exists on a spectrum from early, asymptomatic changes to advanced stages that can result in permanent central vision impairment, affecting the ability to read, recognise faces, and perform detail-oriented tasks. Key risk factors include advancing age, smoking, a family history of AMD, cardiovascular disease, and prolonged ultraviolet light exposure, while high blood pressure and obesity may also contribute. A thorough assessment of medical history, lifestyle factors, and specialised retinal investigations is essential to understand the stage and type of AMD and to guide any management decisions.
Individual assessmentEvery case is different
Complete evaluationUnderstand the condition first
Specialist reviewChoose the right approach
Medical assessment helps clarify severity and identify appropriate options.
Treatment options for Age-related Macular Degeneration (AMD)
Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
Anti-VEGF intravitreal injections are a minimally invasive outpatient treatment in which a medication is injected directly into the vitreous cavity of the eye to block abnormal blood vessel growth and leakage.
Why it may be consideredThey are the standard of care for diabetic retinopathy/diabetic macular edema and age-related macular degeneration (AMD), helping to preserve or improve vision and prevent further retinal damage. The procedure is quick, performed under topical anesthesia, and usually repeated in a series over several months as part of a treatment protocol.
Age-related Macular Degeneration (AMD) is a progressive retinal condition affecting central vision, common in patients above 50 years.
Why it may be consideredManagement focuses on slowing disease progression, preserving remaining vision, and improving quality of life through medical, injectable, or supportive therapies depending on whether the AMD is 'dry' or 'wet' type.
Many international patients consider India for age-related macular degeneration (amd) treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
How this directory is built
Doctors are matched using the specialty, location, condition (Age-related Macular Degeneration (AMD)) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Age-related Macular Degeneration (AMD) in Mumbai, India
What is Age-related Macular Degeneration (AMD)?
Age-related macular degeneration (AMD) is a degenerative condition of the macula — the central part of the retina — that gradually damages central vision, typically in people aged 50 and older. It occurs in two principal forms: dry AMD, which progresses slowly through the accumulation of drusen (protein and lipid deposits) and retinal cell atrophy, and wet AMD, which involves abnormal blood vessel growth beneath the retina and can cause more rapid vision loss.
What are the symptoms and health risks of Age-related Macular Degeneration (AMD)?
Early AMD may produce no noticeable symptoms, while intermediate or advanced stages can cause blurred or distorted central vision, difficulty reading or seeing fine detail, a need for brighter lighting, and the perception of straight lines appearing wavy or bent — a symptom assessed using a grid tool called an Amsler chart. In advanced wet AMD, a dark or blank spot (scotoma) may develop in the centre of the visual field, and colours may appear less vivid. It is important to note that these symptoms can overlap with other retinal and ocular conditions, and their presence alone does not confirm a diagnosis of AMD.
How is Age-related Macular Degeneration (AMD) diagnosed?
Diagnosis is typically established through a comprehensive dilated eye examination combined with specialised imaging, most importantly optical coherence tomography (OCT), which provides detailed cross-sectional images of the retina and macula and allows clinicians to detect and grade structural changes including drusen size and distribution, geographic atrophy, and the presence of subretinal fluid or choroidal neovascularisation. Fundus photography and, where wet AMD is suspected, fluorescein or OCT angiography may also be used to map abnormal blood vessel activity. AMD severity is commonly categorised using established grading systems such as the Age-Related Eye Disease Study (AREDS) scale, which helps stratify risk of progression and inform treatment planning.
How is Age-related Macular Degeneration (AMD) treated?
The appropriate management of AMD depends on its type, stage, and rate of progression as determined by a qualified ophthalmologist following full clinical assessment. Dry AMD, particularly in early and intermediate stages, is often managed through monitoring, lifestyle modification, and nutritional supplementation, while advanced dry AMD with geographic atrophy has limited but emerging treatment options. Wet AMD — and some cases of advanced dry AMD — is primarily treated with intravitreal anti-VEGF injections, a procedural intervention administered directly into the eye to suppress abnormal blood vessel growth and limit further vision loss; the number and frequency of injections required varies by individual response and is decided by the treating clinician.
Can Age-related Macular Degeneration (AMD) be treated without surgery?
Non-procedural management plays a meaningful role in AMD care, particularly for early and intermediate dry AMD, and typically includes regular monitoring with OCT and dilated eye exams, high-dose antioxidant and zinc supplementation based on the AREDS2 formula (for eligible patients at intermediate or advanced risk), smoking cessation, management of cardiovascular risk factors, and the use of protective eyewear to reduce UV exposure. For wet AMD or advanced dry AMD, non-surgical measures alone are generally insufficient to prevent significant vision loss, and procedural treatment such as anti-VEGF injections is usually recommended — though the timing and approach depend on individual clinical assessment.
When is Anti-VEGF Intravitreal Injections considered for Age-related Macular Degeneration (AMD)?
Anti-VEGF Intravitreal Injections may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.
Which doctor treats Age-related Macular Degeneration (AMD)?
AMD is evaluated and managed by a retinal specialist — an ophthalmologist with subspecialty training in diseases and surgery of the retina and vitreous — who will conduct retinal imaging and interpret grading to guide treatment. In some settings, a general ophthalmologist may identify and initially assess AMD before referring to a vitreoretinal subspecialist for ongoing management of intermediate or advanced disease.
How do I choose a doctor for Age-related Macular Degeneration (AMD)?
When selecting a specialist for AMD care, it is worth considering the clinician's specific experience in retinal disease and AMD management, their access to up-to-date retinal imaging technology such as OCT and angiography, and whether the facility supports a structured follow-up programme, since AMD — particularly wet AMD treated with anti-VEGF injections — typically requires ongoing monitoring and repeated clinic visits to assess treatment response and adjust the care plan.
What documents do international patients need to share for a medical evaluation?
Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.
